Fundraising Fox
🦊/People
Sign in

Mary Wheeler

Investor

Managing Director at BioRock Ventures

Bay Area, CA

Kauffman Fellow · Class 18

Find your path to Mary

234 people in our graph share verified history with Mary — schools, employers, funds. One of them is your warm intro.

Karthik ArdhanareeswaranunlockedMary: together at Johnson & Johnson (2013)
×6Mary: together at Kauffman Fellows Program
×4Mary: together at AngelList
Mary: together at Johnson & Johnson

About

Founding managing partner of BioRock Ventures with two decades of therapeutics operating experience, beginning as a startup founder in Boston and later leading M&A, licensing, and strategy at pharmaceutical companies including Johnson & Johnson and Forest (now Allergan/AbbVie). She has consulted as CBO for dozens of early-stage ventures and, over the past decade, helped seed two companies that each achieved IPO exits valued over $1 billion. She is a Kauffman Fellow with an MBA from MIT Sloan, a PhD from Princeton, and an undergraduate degree from Yale.

Contact· self-published, not guessed

Experience

  1. BioRock VenturesInvestor, Founding Managing Director, GPcurrent2019 — presentSan Francisco Bay Area
  2. AngelListInvestor AngelList Syndicate, Therapeutics2017 — 2021
  3. Seed, Series A biotechnology, life sciences and food tech companiesChief Business Officer/Advisor/Consultant to startups and growing companies2014 — 2021California, NY, Canada, Australia, China
  4. StartX;IndieBio; ELabNYC; Other AcceleratorsMentor2014 — 2020California, Canada and NYC
  5. Kauffman Fellows ProgramKauffman Fellow, Class 182013 — 2015Palo Alto, CA
  6. Johnson & JohnsonInnovation Center, New Venture Partnerships and Transactions2013 — 2014Menlo Park, Ca
  7. Forest Laboratories (Allergan | Abbvie)M&A, Licensing and Strategic Planning2008 — 2012New York, NY
  8. Ariston Pharmaceuticals (now part of Pfizer)Co-Founder, CBO2004 — 2008Boston, Massachusetts, United States

Skills & more

CEO supportCEO SuccessionLicensing NegotiationsBoard LevelStrategy6Working with InvestorsNew Venture FormationNew Business DevelopmentConsultingContract ManagementBusiness Case ModellingNew Venture Development
+8 moreContract DraftingAngel InvestingBiopharmaceuticalsContract NegotiationBiotechnologyVenture CapitalMergers & AcquisitionsStart-ups

From Mary's professional profile.

Deals · 2

VaxcyteSolo GP

via BioRock Ventures

AN2Solo GP

via BioRock Ventures

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Frequently asked questions

Who is Mary Wheeler?
Founding managing partner of BioRock Ventures with two decades of therapeutics operating experience, beginning as a startup founder in Boston and later leading M&A, licensing, and strategy at pharmaceutical companies including Johnson & Johnson and Forest (now Allergan/AbbVie). She has consulted as CBO for dozens of early-stage ventures and, over the past decade, helped seed two companies that each achieved IPO exits valued over $1 billion. She is a Kauffman Fellow with an MBA from MIT Sloan, a PhD from Princeton, and an undergraduate degree from Yale.
Where does Mary Wheeler work?
Mary Wheeler is Managing Director at BioRock Ventures.
Where did Mary Wheeler go to school?
Mary Wheeler studied at Yale University (Bachelor of Arts - BA); MIT Sloan School of Management (MBA, New Product and Venture Development Track - Entrepeneurship); Princeton University (PhD, cognitive neuroscience).

Same school

Shared employers

Also worked at BioRock Ventures1

Stephanie JinInvestor at Avestria Ventures